Performance analysis of Bioline Rx (BLRX)
Annual Return
Over the past 3 years, BLRX has had an average annual return of -64.16%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, BLRX has had an average annual return of -53.02%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, BLRX has had an average annual return of -39.86%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jul 27, 2011, BLRX has had an average annual return of -36.91%, underperforming the benchmark SPY, which returned +14.35% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +11.11% | -67.86% | -86.54% | +166.67% | -71.11% | -19.16% | +12.08% | -65.71% | -59.90% | +18.48% | -29.22% | -19.78% |
| 2014 | 2013 | 2012 | 2011 | ||||||||
| -42.34% | +11.05% | -20.18% | -36.98% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +11.11% | -10.00% | -11.11% | +12.50% | +44.44% | -23.08% | +0% | +11.11% | |||||
| 2025 | -57.14% | -8.33% | -9.09% | +10% | +54.55% | -11.76% | -13.33% | +0% | +0% | -15.38% | +0% | -18.18% | -67.86% |
| 2024 | -24.04% | +11.39% | -15.91% | -39.86% | +11.24% | -23.23% | +36.84% | -17.31% | -17.44% | -23.94% | -25.93% | -30.00% | -86.54% |
| 2023 | +6.41% | -4.82% | +48.10% | +21.37% | +47.18% | +0.96% | -3.32% | +13.73% | +3.88% | -17.43% | -3.52% | +8.33% | +166.67% |
| 2022 | -10.74% | -16.60% | +12.94% | -28.63% | +27.78% | -17.87% | +2.94% | +14.86% | -38.81% | -8.94% | -16.96% | -16.13% | -71.11% |
| 2021 | +10.78% | +10.81% | -9.76% | +12.43% | -8.89% | -1.85% | +15.05% | -11.21% | -4.21% | +3.30% | -7.18% | -22.64% | -19.16% |
| 2020 | +5.03% | -20.45% | -29.32% | +26.70% | +15.25% | -11.67% | +32.60% | -19.93% | -9.96% | +20.74% | +16.03% | +9.87% | +12.08% |
| 2019 | +50.98% | -37.88% | +4.91% | -9.36% | -7.61% | +2.79% | -28.53% | -28.14% | -7.41% | -1.14% | +0.29% | -14.12% | -65.71% |
| 2018 | -1.85% | -6.54% | -12.98% | -8.09% | +16.29% | -4.33% | -1.07% | +5.66% | +15.04% | -34.56% | -2.87% | -35.72% | -59.90% |
| 2017 | +10.88% | +12.48% | -16.26% | -10.47% | -3.51% | +1.82% | +26.61% | -2.77% | +7.69% | -7.14% | +5.75% | -0.91% | +18.48% |
Drawdown analysis of Bioline Rx (BLRX)
The maximum drawdown for the BLRX was -99.94%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current BLRX drawdown is -99.91%.
Since Jul 27, 2011 BLRX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.94% | Jan 24, 2012 | 3565 | Mar 30, 2026 | Ongoing | Ongoing | Ongoing |
| -49.41% | Aug 1, 2011 | 29 | Sep 12, 2011 | 92 | Jan 24, 2012 | 121 |
| -5.77% | Jul 27, 2011 | 1 | Jul 28, 2011 | 1 | Jul 29, 2011 | 2 |